Results 151 to 160 of about 3,956,965 (389)
The first use of face mask in the history of medicine. [PDF]
Infect Control Hosp Epidemiol, 2022 Taghizadieh A +3 more
europepmc +1 more source
The history of aeronautical medicine in Venezuela [PDF]
The Aerial Medical Service of the Ministry of Transportation and Communications of Venezuela was created on June 1949, and later became the Department of Aeronautical Medicine.
Iriarte, D. R.
core +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Molecular Oncology, EarlyView.Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
History with Heart-and Impact: The National Library of Medicine Michael E. DeBakey Fellowship in the History of Medicine. [PDF]
Methodist Debakey Cardiovasc J, 2021 Reznick JS, Koyle KM.
europepmc +1 more source
Evidence-Based Medicine: History, Review, Criticisms, and Pitfalls [PDF]
, 2023 Iqbal Ratnani +4 more
openalex +1 more source
Art and the Human Condition: Incorporating Visual Analysis of Artworks into a Undergraduate Pre-Medicine Curriculum [PDF]
, 2012 This thesis project presents a sample class session for the course, The Human Condition: An Arts Perpective (ARTH 361), which will be a part of the optional Medical Humanities minor for the pre-medicine students at Virginia Commonwealth University (VCU)
Fuqua, Elizabeth
core +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Clinical Pharmacology in the UK, c.1950-2000: Industry and Regulation [PDF]
, 2008 Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.First published by the Wellcome Trust Centre for the ...
Reynolds, LA, Tansey, EM
core
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source